VOYA Investment Management
CLVS

VOYA Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

VOYA Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-41,932
Closed -$85K – 2952
2022
Q1 		$85K Hold
41,932
– – ﹤0.01% 2535
2021
Q4 		$114K Sell
41,932
-1,759
-4% -$6.5K ﹤0.01% 2652
2021
Q3 		$195K Buy
43,691
+4,097
+10% +$19.7K ﹤0.01% 2587
2021
Q2 		$230K Buy
39,594
+3,689
+10% +$21.6K ﹤0.01% 2528
2021
Q1 		$252K Buy
35,905
+1,332
+4% +$8.93K ﹤0.01% 2410
2020
Q4 		$166K Buy
34,573
+6,781
+24% +$34.3K ﹤0.01% 2479
2020
Q3 		$162K Buy
27,792
+2,689
+11% +$16.1K ﹤0.01% 2223
2020
Q2 		$169K Buy
25,103
+398
+2% +$3.01K ﹤0.01% 2212
2020
Q1 		$157K Hold
24,705
– – ﹤0.01% 2215
2019
Q4 		$258K Buy
24,705
+4,654
+23% +$33.8K ﹤0.01% 2257
2019
Q3 		$79K Sell
20,051
-357,726
-95% -$2.89M ﹤0.01% 2449
2019
Q2 		$5.62M Buy
377,777
+74,302
+24% +$1.34M 0.01% 773
2019
Q1 		$7.53M Sell
303,475
-433,713
-59% -$10.9M 0.02% 662
2018
Q4 		$13.2M Sell
737,188
-28,432
-4% -$581K 0.03% 458
2018
Q3 		$22.5M Buy
765,620
+124,050
+19% +$4.8M 0.05% 398
2018
Q2 		$29.2M Buy
641,570
+104,114
+19% +$5.06M 0.06% 334
2018
Q1 		$28.4M Buy
537,456
+103,457
+24% +$6.04M 0.06% 324
2017
Q4 		$29.5M Buy
433,999
+22,989
+6% +$1.61M 0.06% 324
2017
Q3 		$33.9M Buy
411,010
+216,041
+111% +$17.1M 0.07% 284
2017
Q2 		$18.3M Buy
194,969
+10,008
+5% +$612K 0.04% 423
2017
Q1 		$11.8M Buy
184,961
+172,492
+1,383% +$10.5M 0.03% 562
2016
Q4 		$554K Sell
12,469
-2,020
-14% -$71.1K ﹤0.01% 1673
2016
Q3 		$522 Hold
14,489
– – ﹤0.01% 1701
2016
Q2 		$199K Buy
14,489
+2,483
+21% +$36.3K ﹤0.01% 2270
2016
Q1 		$231K Hold
12,006
– – ﹤0.01% 2153
2015
Q4 		$420K Sell
12,006
-129,439
-92% -$8.35M ﹤0.01% 1833
2015
Q3 		$13M Buy
141,445
+32,875
+30% +$2.85M 0.03% 464
2015
Q2 		$9.54M Sell
108,570
-63,678
-37% -$5.45M 0.02% 608
2015
Q1 		$12.8M Sell
172,248
-66,224
-28% -$4.68M 0.03% 503
2014
Q4 		$13.4M Sell
238,472
-18,425
-7% -$968K 0.03% 493
2014
Q3 		$11.7M Buy
256,897
+50,062
+24% +$2.09M 0.03% 540
2014
Q2 		$8.56M Buy
206,835
+76,420
+59% +$3.94M 0.02% 659
2014
Q1 		$9.03M Buy
130,415
+120,392
+1,201% +$8.84M 0.02% 615
2013
Q4 		$604K Buy
10,023
+1,087
+12% +$59.1K ﹤0.01% 1816
2013
Q3 		$543K Hold
8,936
– – ﹤0.01% 1836
2013
Q2 		$599K Buy
+8,936
New +$402K ﹤0.01% 1697

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

VOYA Investment Management's CLVS Position: Q2 2022 in Review

VOYA Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 41,932 shares — an estimated $85K sold.

VOYA Investment Management first reported a position in CLVS in Q2 2013 and held it in 36 quarters. The position peaked at $33.9M in Q3 2017. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • VOYA Investment Management reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 41,932 Clovis Oncology, Inc. shares in Q2 2022, an estimated $85K.
  • VOYA Investment Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 36 quarters.
  • VOYA Investment Management's Clovis Oncology, Inc. position peaked at $33.9M in Q3 2017.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.